Starlix

Nateglinide

Nateglinide (INN, trade name Starlix) is a drug for the treatment of type 2 diabetes. Nateglinide was developed by Ajinomoto, a Japanese company and sold by the Swiss pharmaceutical company Novartis. Nateglinide belongs to the meglitinide class of blood glucose-lowering drugs. Contents 1 Pharmacology 2 Contraindications 3 Comparisons with other drugs for type 2 diabetes 4 Dosage 5 See also 6 References 7 External links Pharmacology Nateglinide lowers blood glucose by stimulating the re...

Drug Index

Nateglinide (INN, trade name Starlix) is a drug for the treatment of type 2 diabetes. Nateglinide was developed by Ajinomoto, a Japanese company and sold by the Swiss pharmaceutical company Novartis. Nateglinide belongs to the meglitinide class of blood glucose-lowering drugs. Contents 1 Pharmacology 2 Contraindications 3 Comparisons with other drugs for type 2 diabetes 4 Dosage 5 See also 6 References 7 External links Pharmacology Nateglinide lowers blood glucose by stimulating the re...

NDC Database

Starlix 60 mg Oral Tablet by Novartis Pharmaceuticals Corporation ## Markings: STARLIX;60 ## Shape: Round ## Color: Pink ## Package Codes: 0078-0351-05 ## Active Ingredients: Nateglinide

NDC Database

Starlix 120 mg Oral Tablet by Novartis Pharmaceuticals Corporation ## Markings: STARLIX;120 ## Shape: Oval ## Color: Yellow ## Package Codes: 0078-0352-05 ## Active Ingredients: Nateglinide